×
About 768 results

ALLMedicine™ Cardiac Testing Center

Research & Reviews  194 results

Differences in cardiac testing resource utilization using two different risk stratifica...
https://doi.org/10.1016/j.ajem.2022.12.023
The American Journal of Emergency Medicine; Tyner RJ, Whittington MD et. al.

Jan 16th, 2023 - Assess whether changing an emergency department (ED) chest pain pathway from utilizing the Thrombolysis in Myocardial Infarction (TIMI) score for risk stratification to an approach utilizing the History, EKG, Age, Risk, Troponin (HEART) score was ...

Coronary calcium score in the initial evaluation of suspected coronary artery disease.
https://doi.org/10.1136/heartjnl-2022-321682
Heart (British Cardiac Society); Pedersen ER, Hovland S et. al.

Dec 23rd, 2022 - We evaluated coronary artery calcium (CAC) scoring as an initial diagnostic tool in outpatients and in patients presenting at the emergency department due to suspected coronary artery disease (CAD). 10 857 patients underwent CAC scoring and corona...

Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease
https://clinicaltrials.gov/ct2/show/NCT03660969

Dec 12th, 2022 - Introduction: The detection of cardiomyocyte injury as quantified by blood concentrations of cardiac troponin T (cTnT) or I (cTnI) is central in the diagnosis of acute myocardial infarction (AMI). While multiple cardiac disorders other than AMI ma...

Outcomes of Liver Transplantation in Patients with Preexisting Coronary Artery Disease.
https://doi.org/10.1097/TP.0000000000004402
Transplantation Reznicek E, Sasaki K et. al.

Nov 19th, 2022 - Advances in surgical and medical technology over the years has made liver transplantation possible for older and higher risk patients. Despite rigorous preoperative cardiac testing, cardiovascular events remain a major cause of death after orthoto...

High Sensitivity Troponins.
https://doi.org/10.1016/j.emc.2022.07.002
Emergency Medicine Clinics of North America; Hempel TT, Wyatt A

Nov 18th, 2022 - High-sensitivity cardiac troponin (hs-cTn) assays are highly specific to cardiac tissue and can detect small amounts of myocardial injury rapidly. Hs-cTn assays are the recommended cardiac biomarkers in the major US and European guidelines. In the...

see more →

Clinicaltrials.gov  34 results

Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease
https://clinicaltrials.gov/ct2/show/NCT03660969

Dec 12th, 2022 - Introduction: The detection of cardiomyocyte injury as quantified by blood concentrations of cardiac troponin T (cTnT) or I (cTnI) is central in the diagnosis of acute myocardial infarction (AMI). While multiple cardiac disorders other than AMI ma...

Cardiotoxicities in Patients Receiving BTKi
https://clinicaltrials.gov/ct2/show/NCT05521178

Aug 30th, 2022 - This research study includes three visits for research blood, physical exam, and cardiac testing at baseline, 3 months, and 6 months. The study will collect the following data during the 6-month study period: Blood sample collection Electrocardiog...

The Natural History of Danon Disease
https://clinicaltrials.gov/ct2/show/NCT03766386

May 12th, 2022 - The study design will include: Collection of information for all patients from: Survey of patient or caregiver (if the patient has deceased) Medical Charts Collection of information from living patients assessed by the multidisciplinary team at th...

The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing
https://clinicaltrials.gov/ct2/show/NCT04767958

May 2nd, 2022 - This RAPID COVID-19 study is a prospective, unblinded clinical trial. POC testing utilizing the Spartan Cube COVID-19 platform will be performed on a cohort of 2200 hospitalized patients who have been tested for COVID-19. This cohort will be divid...

Use of Visual Decision Aid for Shared Decision Making in Chest Pain
https://clinicaltrials.gov/ct2/show/NCT03674021

Apr 20th, 2022 - Chest pain is a common presenting complaint in the Emergency Department (ED). Cardiac testing in low-risk patients poses unnecessary costs and resource utilisation, which may in part be due to clinicians adopting a very-low-risk threshold for disc...

see more →

News  79 results

Global Return of Cardiac Testing Uneven, Staff Stress a Factor
https://www.medscape.com/viewarticle/974068

May 16th, 2022 - A new study finds that cardiovascular diagnostic testing has yet to return to prepandemic levels in some regions of the world, and that excess pandemic-related stress among physicians and testing staff may be slowing that recovery. The INCAPS COVI...

New ACC Guidance on Cardiovascular Consequences of COVID-19
https://www.medscape.com/viewarticle/970467

Mar 17th, 2022 - The American College of Cardiology (ACC) has issued an expert consensus clinical guidance document for the evaluation and management of adults with key cardiovascular consequences of COVID-19. The document makes recommendations on how to evaluate ...

ACC Issues Playbook for Long COVID With Cardiac Involvement
https://www.medpagetoday.com/infectiousdisease/covid19/97701

Mar 16th, 2022 - People with long COVID and cardiovascular symptoms may now follow a prescribed path for evaluation and treatment recommended by the American College of Cardiology (ACC). According to the new guidance, people with post-acute sequelae of SARS-CoV-2 ...

ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/97043

Feb 4th, 2022 - The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously backed the fully approved Moderna COVID-19 vaccine (Spikevax), but engaged in serious discussion over the dosing interval for both Moderna and Pfizer's mRNA vaccines. In a s...

Experts Answer Audience Questions Related to Adverse Events of BTKi
https://www.onclive.com/view/experts-answer-audience-questions-related-to-adverse-events-of-btki

Oct 21st, 2021 - Carrie Lenneman, MD, MSCI: In light of time, I’ll move to a couple of questions if you’re ready for that. Farrukh Awan, MD: Yes. Carrie Lenneman, MD, MSCI: The first one is, Have you seen low heart rate or bradycardia with ibrutinib? I ca...

see more →